Evidence map›Paper›PMID 25858675›Full record

ArticleNature communications2015

Controlled induction of DNA double-strand breaks in the mouse liver induces features of tissue ageing.

Ryan R White, Brandon Milholland, Alain de Bruin, Samuel Curran, Remi-Martin Laberge, Harry van Steeg, Judith Campisi, Alexander Y Maslov, Jan Vijg

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 109 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Emerging Vistas for the NutraceuticalPharmaceuticals (Basel, Switzerland) · 2024
    Review
  10. Article
  11. Review
  12. Review
  13. Cellular senescence in skeletal disease: mechanisms and treatment.Cellular & molecular biology letters · 2023
    Review
  14. Article
  15. Article
  16. Putting aging on ICE.Cell metabolism · 2023
    Article
  17. Review
  18. Article
  19. Review
  20. The Roles of Myeloid Cells in Aging-related Liver Diseases.International journal of biological sciences · 2023
    Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Ryan R WhiteDepartment of Genetics, Albert Einstein College of Medicine, 1301 Morris Park Avenue, Bronx, New York 10461, USA.
Brandon MilhollandDepartment of Genetics, Albert Einstein College of Medicine, 1301 Morris Park Avenue, Bronx, New York 10461, USA.
Alain de BruinFaculty of Veterinary Medicine, Department of Pathobiology, Dutch Molecular Pathology Center, Utrecht University, Yalelaan1, 3584 CL Utrecht, The Netherlands.
Samuel CurranBuck Institute for Research on Aging, 8001 Redwood Boulevard, Novato, California 94945, USA.
Remi-Martin LabergeBuck Institute for Research on Aging, 8001 Redwood Boulevard, Novato, California 94945, USA.
Harry van SteegNational Institute of Public Health and the Environment (RIVM), Antonie van Leeuwenhoeklaan 9, MA 3721 Bilthoven, The Netherlands.
Judith Campisi1] Buck Institute for Research on Aging, 8001 Redwood Boulevard, Novato, California 94945, USA [2] Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, California 94720, USA.
Alexander Y MaslovDepartment of Genetics, Albert Einstein College of Medicine, 1301 Morris Park Avenue, Bronx, New York 10461, USA.
Jan VijgDepartment of Genetics, Albert Einstein College of Medicine, 1301 Morris Park Avenue, Bronx, New York 10461, USA.
Albert Einstein College of Medicine · USBuck Institute for Research on Aging · USNational Institute for Public Health and the Environment · NLUtrecht University · NL

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI THOMAS E ROHAN · 1985 to 2026
$111.2M
THE IMPACT OF CELLULAR DEFENSE ON THE ROLE OF Ku80 IN GENOME MAINTENANCE AND LONGP01AG017242 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI VIJG, JAN · 1999 to 2023
$46.1M
Einstein's Nathan Shock Center of Excellence in Basic Biology of AgingP30AG038072 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI VIJG, JAN · 2010 to 2024
$10.8M
NCI NIH HHS P30 CA013330NIA NIH HHS 5P30AG038072-05NIA NIH HHS P01 AG017242NIA NIH HHS P30 AG038072
6 · The paper itself

Abstract

DNA damage has been implicated in ageing, but direct evidence for a causal relationship is lacking, owing to the difficulty of inducing defined DNA lesions in cells and tissues without simultaneously damaging other biomolecules and cellular structures. Here we directly test whether highly toxic DNA double-strand breaks (DSBs) alone can drive an ageing phenotype using an adenovirus-based system based on tetracycline-controlled expression of the SacI restriction enzyme. We deliver the adenovirus to mice and compare molecular and cellular end points in the liver with normally aged animals. Treated, 3-month-old mice display many, but not all signs of normal liver ageing as early as 1 month after treatment, including ageing pathologies, markers of senescence, fused mitochondria and alterations in gene expression profiles. These results, showing that DSBs alone can cause distinct ageing phenotypes in mouse liver, provide new insights in the role of DNA damage as a driver of tissue ageing.

Indexed as

DNA Breaks, Double-StrandedDNA RepairAdenoviridaeAgingAnimalsBiomarkersDeoxyribonucleases, Type II Site-SpecificDNAGene Expression ProfilingGene Expression RegulationGenetic VectorsLiverMaleMiceMice, Inbred BALB CTetracyclineBiomarkersDeoxyribonucleases, Type II Site-SpecificDNAendodeoxyribonuclease SacITetracycline

Identifiers

PMID25858675
PMCPMC4394211
OpenAlexW2146010728

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.